Premarket Notification for a New Dietary Ingredient

Forms and Documents

Document	Type	Status	Availability
SS-0910-0330 rev. 08-24-2011.doc	Supporting Statement A	Uploaded 2011-08-25	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
5914	Reporting - Submission of a Premarket Notification for a New Dietary Ingredient		Modified

ICR Details

OMB Control No: 0910-0330	ICR Reference No: 201108-0910-010
Status: Historical Active	Previous ICR Reference No: 200807-0910-003
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: Premarket Notification for a New Dietary Ingredient
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 11/06/2011
	Date Received in OIRA: 08/25/2011
Terms of Clearance: In accordance with the terms of 5 CFR 1320, OMB approves this collection of information for a period of two years. OMB notes that FDA has not provided a means for respondents to submit this information electronically. FDA should make such electronic response available when this collection is resubmitted for approval. Further, OMB notes that FDA received multiple comments indicating that the true burden of this collection is higher than FDA has estimated. FDA should conduct outreach to the affected community and prepare a full response to these comment - and a re-estimation of the burden, if appropriate - before resubmitting this ICR for approval.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	11/30/2013	36 Months From Approved	11/30/2011
Responses	55	0	71
Time Burden (Hours)	1,100	0	1,420
Cost Burden (Dollars)	0	0	0

---

Abstract: Consistent with Section 413 (a) of the Federal Food, drug and Cosmetic Act(21 U.S.C. 350b(a)), FDA requires each manufacturer or distributor of a dietary supplement containing a new dietary ingredient, or of a new dietary ingredient , to submit a notification of the basis for their conclusion that said supplement or ingredient will reasonably be expected to be safe.

---

Authorizing Statute(s): US Code: 21 USC 350b(a) Name of Law: null
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	76 FR 32214	06/03/2011
30-day Notice:	Federal Register Citation:	Citation Date:
	76 FR 51986	08/19/2011
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Reporting - Submission of a Premarket Notification for a New Dietary Ingredient

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	55	71	0	0	-16	0
Annual Time Burden (Hours)	1,100	1,420	0	0	-320	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $1,388,848

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/25/2011

---